Hims & Hers Health has been on a meteoric rise, capturing the attention of investors and consumers alike. In just 60 days, the stock has surged from $32 to $68 per share—an extraordinary 100% gain.

Hims & Hers Health (ticker: HIMS) has steadily risen from $7 to $30 per share, but it remains one of the most misunderstood companies in the market.

When economic uncertainties arise, investors tend to react by selling stocks across the board. Yet, there are companies that not only weather recessions but thrive during them. **HIMS & HERS Health Inc.**, a telehealth pioneer, stands out as one such example. Here's why HIMS remains a compelling investment, even in the face of economic downturns.

I still find this stock dirt cheap, especially now that we trended back towards 25 bucks. This is a stock that peaked at around 34, and I find it just as compelling as in 2024. I think we're going to have a wonderful 2025. This is my first coverage of HIMS for 2025, so let's dive in!